CellNetix Pathology & Laboratories
- Company typePrivate
- Founded2005
- HeadquartersSeattle, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
CellNetix Pathology & Laboratories firmographics
Firmographics- Name
- CellNetix Pathology & Laboratories
- Legal name
- CellNetix Pathology & Laboratories, LLC
- Website
- https://cellnetix.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
CellNetix Pathology & Laboratories industry classification
Industry- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industries
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where CellNetix Pathology & Laboratories is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
CellNetix Pathology & Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
Revenue model
- Pathology Testing Services: Professional pathology diagnostic services billed per CPT codes. Services include surgical pathology, molecular testing, cytology, immunohistochemistry, and flow cytometry. Multiple CPT codes may be billed for multiple biopsies, IHC stains, and flow markers.
- Laboratory Technical Services: Technical component of laboratory testing including specimen processing, staining, and analysis
- Client Portal Services: Atlas web portal for ordering tests, viewing results, and supply requests for healthcare facilities
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard Pathology Services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
CellNetix Pathology & Laboratories product offering
Product offeringCore offering
CellNetix Pathology & Laboratories is a private regional pathology group headquartered in Seattle, Washington that delivers anatomic, clinical, molecular, hematopathology, and women's health diagnostic services through more than 60 board-certified pathologists covering 25+ medical subspecialties. The company supports hospitals, clinics, and physician practices across Washington, Oregon, Idaho, Alaska, and Arizona with routine and specialized diagnostic testing, advanced molecular assays (including SymGene NGS cancer panels), and digital pathology workflow tools such as the Atlas client portal.
Product overview
CellNetix Pathology & Laboratories operates as a comprehensive pathology services provider offering a unified portfolio of diagnostic services. The core offerings include Anatomic Pathology Services and Clinical Pathology Services across 25+ subspecialties, supported by 60+ board-certified pathologists. The Molecular Pathology division provides specialized testing through the SymGene79 NGS Cancer Panel and related focus panels. The Atlas Portal serves as the primary digital interface for healthcare professionals to access results, order tests, and manage supplies. The company also provides specialized services in hematopathology and women's health, with a focus on cancer diagnostics and personalized medicine through genetic testing.
Differentiator
Problem solved
Functional benefit
Brands
- Atlas Portal: A web portal for physicians and healthcare staff to view patient results, order lab tests and supplies, and request courier pickups.
- SymGene79™ NGS Cancer Panel
Products and services
- Anatomic Pathology Services Subspecialty anatomic pathology interpretation of biopsy, surgical, and cytology specimens, delivered by 60+ board-certified pathologists across 25+ subspecialties to hospitals, clinics, and physician practices.
- Clinical Pathology / Laboratory Testing Clinical laboratory testing service that supports routine and specialized clinical diagnostics, run through the Sunquest Mitogen laboratory information system for referring healthcare providers.
- Molecular Pathology (SymGene NGS Cancer Panels) In-house molecular oncology diagnostic testing using next-generation sequencing panels (SymGene79 NGS Cancer Panel, SymGene Focus panels, and SymGene Myeloid Panel) to support cancer and myeloid disease workups for referring oncologists and hospitals.
- Hematopathology Services Specialized hematopathology diagnostic service covering blood, bone marrow, and lymph node specimens, including molecular myeloid workups, for referring hematologists, oncologists, and hospitals.
- Women's Health Pathology Specialized women's health pathology service covering gynecologic cytology, breast, and related diagnostic interpretation, designed for OB/GYN and women's health practices and the hospitals that support them.
- Atlas Portal Online portal that gives referring clinicians and patients electronic access to order entry, result retrieval, and specimen logistics for CellNetix pathology and laboratory services.
Quantifiable outcome
- Precise diagnoses through peer-to-peer collaboration across 25+ subspecialties
- +3 more outcomes
Companies that use CellNetix Pathology & Laboratories
Customer profileNamed customers2 records
Segments3 records
CellNetix Pathology & Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature5 records
CellNetix Pathology & Laboratories partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and strategic.
- ProsciacoreCellNetix partnered with Proscia, a leading digital and computational pathology solutions provider, to digitize its pathology practice. The partnership involves digitizing 1 million glass slides per year using Proscia's digital pathology platform. This enables CellNetix to achieve greater workflow flexibility, productivity gains, streamlined collaboration among distributed pathologists, and positions the company to leverage AI for future insights. CellNetix was presented an award from Proscia for advancing AI in Clinical Practice.
- SpIntellxstrategicCollaboration to validate SpIntellx's HistoMapr-Breast platform for spatial analytics and explainable AI (xAI) in digital pathology. This platform is designed to triage cases to subspecialists, perform retroactive quality assurance, reduce intra- and inter-pathologist discordance, provide transparent AI guidance, and facilitate standardized reporting. Dr. Dominique Coco serves as lead project pathologist.
- Sunquest Information SystemscoreSunquest partnered with N-of-One and CellNetix to integrate N-of-One's clinical interpretation solutions into Sunquest Mitogen LIMS software. CellNetix served as the first customer ship (FCS) for this integration. The partnership streamlines delivery of time-critical genetic reports with clinical interpretation for next generation sequencing (NGS) panels, supporting precision medicine initiatives.
- N-of-OnecoreN-of-One provides clinical interpretation for molecular diagnostics in oncology. Through the Sunquest partnership, N-of-One's content enables creation of reports including biomarker-driven therapies, clinical trials, genetic variant interpretation, and treatment identification. CellNetix was the first customer ship for this integration.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
CellNetix Pathology & Laboratories competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: Largest U.S. clinical laboratory network offering anatomic pathology, molecular diagnostics, and hospital reference lab services nationwide. Comparable to CellNetix as a full-service diagnostic provider with hospital/physician channels, though much larger and more diversified.
- Laboratory Corporation of America (Labcorp): National clinical and anatomic pathology reference lab serving hospitals, physicians, and biopharma. Directly comparable to CellNetix in anatomic and molecular pathology offerings, with substantially broader geographic reach and biopharma central lab services.
- ARUP Laboratories: Nonprofit reference laboratory affiliated with the University of Utah offering esoteric testing, anatomic pathology, and molecular diagnostics. Comparable to CellNetix in providing specialty reference testing and academic-grade subspecialty expertise to hospitals.
- Sonic Healthcare USA: Subsidiary of Sonic Healthcare operating multiple regional pathology and laboratory brands across the U.S. Comparable to CellNetix as a multi-regional anatomic and clinical pathology provider with subspecialty focus and hospital medical directorships.
- Foundation Medicine (Roche): Comprehensive genomic profiling for oncology within Roche. Comparable to CellNetix as a tumor NGS provider serving oncologists and biopharma, but with broader national reach and larger clinical evidence base.
Direct peers
- PathGroup: Private, physician-led anatomic and clinical pathology practice serving hospitals, clinics, and physicians across the Southeast and beyond. Closely comparable to CellNetix as a similarly scaled independent pathology group with subspecialty coverage and molecular capabilities.
- NeoGenomics Laboratories: Specialized oncology-focused clinical laboratory providing molecular and anatomic pathology services to community hospitals and oncologists. Comparable to CellNetix in NGS-based oncology profiling and hospital-channel molecular diagnostics.
Emerging players
- Caris Life Sciences: Molecular diagnostics and AI-driven precision medicine company offering comprehensive tumor profiling. Comparable to CellNetix as an NGS-based oncology testing provider, though more focused on biopharma and advanced molecular profiling than routine anatomic pathology.
- Guardant Health: Liquid biopsy and oncology molecular diagnostics company. Partial overlap with CellNetix's SymGene79 NGS panel as a molecular oncology testing competitor, though differentiated by blood-based versus tissue-based profiling.
Others
- Proscia: Digital and computational pathology platform provider and direct technology partner of CellNetix. Comparable not as a competitor but as the platform underpinning CellNetix's digital pathology transformation, illustrating the broader category of digital pathology vendors shaping the space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
CellNetix Pathology & Laboratories social profiles
Digital presenceCellNetix Pathology & Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
CellNetix Pathology & Laboratories leadership team
Management profileNumber of profiles
CellNetix Pathology & Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CellNetix Pathology & Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CellNetix Pathology & Laboratories
What does CellNetix Pathology & Laboratories do?
CellNetix Pathology & Laboratories is a private regional pathology group headquartered in Seattle, Washington that delivers anatomic, clinical, molecular, hematopathology, and women's health diagnostic services through more than 60 board-certified pathologists covering 25+ medical subspecialties. The company supports hospitals, clinics, and physician practices across Washington, Oregon, Idaho, Alaska, and Arizona with routine and specialized diagnostic testing, advanced molecular assays (including SymGene NGS cancer panels), and digital pathology workflow tools such as the Atlas client portal.
Is CellNetix Pathology & Laboratories a public or private company?
CellNetix Pathology & Laboratories is a private company. It is currently operating.
When was CellNetix Pathology & Laboratories founded?
CellNetix Pathology & Laboratories was founded in 2005. It employs 251 to 500 people.
Where is CellNetix Pathology & Laboratories based?
CellNetix Pathology & Laboratories is headquartered in Seattle, United States, in the North America region.
How does CellNetix Pathology & Laboratories make money?
Three revenue lines are on record. Pathology Testing Services are the primary driver. The others are laboratory Technical Services and client Portal Services.
Who are CellNetix Pathology & Laboratories's main competitors?
Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp), ARUP Laboratories, Sonic Healthcare USA and Foundation Medicine (Roche). Direct peers are PathGroup and NeoGenomics Laboratories. Emerging players are Caris Life Sciences and Guardant Health. Proscia is listed as an others.
Does CellNetix Pathology & Laboratories have an API?
No public API is recorded for CellNetix Pathology & Laboratories.
What industry is CellNetix Pathology & Laboratories in?
Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.